TANG CAPITAL MANAGEMENT LLC - 30 Jun 2025 SCHEDULE 13G/A Report for Outlook Therapeutics, Inc. Common Stock, par value $0.01 per share (OTLK)

Filing Manager: TANG CAPITAL MANAGEMENT LLC
Reporting Manager: TANG CAPITAL MANAGEMENT, LLC
Security: Outlook Therapeutics, Inc. Common Stock, par value $0.01 per share
Symbol: OTLK
Shares outstanding: 44,117,647 shares
Disclosed Ownership: 1,500,000 shares
Ownership: 3.4%
Form type: SCHEDULE 13G/A
Filing time: 14 Aug 2025, 16:15:07 UTC
Date of event: 30 Jun 2025
Previous filing: 15 May 2025
SEC: View on sec.gov

Key filing fact

TANG CAPITAL MANAGEMENT LLC disclosed 3.4% ownership in Outlook Therapeutics, Inc. Common Stock, par value $0.01 per share (OTLK) on 30 Jun 2025.

Key facts

TANG CAPITAL MANAGEMENT LLC filed SCHEDULE 13G/A for Outlook Therapeutics, Inc. Common Stock, par value $0.01 per share (OTLK).
Disclosed ownership: 3.4%.
Date of event: 30 Jun 2025.

This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
You can verify ownership claims directly against the original SEC filing.

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

Reporting persons

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name	Ownership	Shares Owned	shared voting power	Signature	Title
TANG CAPITAL MANAGEMENT, LLC	3.4%	1,500,000	1,500,000	/s/ Kevin Tang	Manager
KEVIN TANG	3.4%	1,500,000	1,500,000	/s/ Kevin Tang	Self
TANG CAPITAL PARTNERS, LP	3.4%	1,500,000	1,500,000	/s/ Kevin Tang	Manager, Tang Capital Management, LLC, General Partner
TANG CAPITAL PARTNERS INTERNATIONAL, LP	0%	0	0	/s/ Kevin Tang	Manager, Tang Capital Management, LLC, General Partner
TANG CAPITAL PARTNERS III, INC	0%	0	0	/s/ Kevin Tang	Chief Executive Officer
TANG CAPITAL PARTNERS IV, INC	0%	0	0	/s/ Kevin Tang	Chief Executive Officer

CIK / CUSIP context first

Broader feeds